Playback speed
10 seconds
Is Progression-Free Survival without Overall Survival Benefit Enough?
By
Beacon Medical Interchange
FEATURING
Jack West
By
Beacon Medical Interchange
FEATURING
Jack West
263 views
October 29, 2018
Dr. Jack West discusses results and the significance of two important Japanese trials that test ...
read more ↘ the combination of erlotinib (Tarceva) with bevacizumab (Avastin), which shows a consistent improvement in progression-free survival but not overall survival.
↖ read less
read more ↘ the combination of erlotinib (Tarceva) with bevacizumab (Avastin), which shows a consistent improvement in progression-free survival but not overall survival.
↖ read less
Login to view comments.
Click here to Login
Lung